VUMC’s Master of Science in Clinical Investigation (MSCI) program is now accepting applications for the 2025-2027 cohort. The program’s priority deadline for merit-based scholarship consideration is Friday, Feb. 28, 2025. The MSCI program is entirely online and provides clinical and translational research education.
Since the program’s inception in 2000, MSCI scholars have published more than 10,500 research articles, including in the New England Journal of Medicine, the Journal of the American Medical Association and Lancet publications. Vanderbilt’s MSCI alums and students have received a total of $24.3M+ as principal investigators of individual K and K-equivalent awards, $155.4M+ as principal investigators of R and R-equivalent awards, $2.4M+ as PI of Bridge (K99/R00) awards, and more than $109.7M in foundation grants. Of the K-awardees, 71.4% were able to convert to an R-award.
Almost 70% of MSCI alums pursue careers in academic medicine; nearly 30% maintaining a career in industry/pharmaceuticals.
The MSCI program at Vanderbilt has maintained a 99% completion rate.
For more information on the MSCI program, visit https://medschool.vanderbilt.edu/msci/. If you’re interested in applying, you can do so at https://medschool.vanderbilt.edu/msci/application/.
